BioCentury
ARTICLE | Clinical News

Neutralase neutralizer of heparin: Completed Phase Ia trial in 32 volunteers in the U.K. who received up to three times the expected clinical dose. The agent wa

August 7, 1995 7:00 AM UTC

Ibex Technologies (TSE:CPM.A), Montreal Product: Neutralase neutralizer of heparin Indication: Bypass surgery Status: Completed Phase Ia trial in 32 volunteers in the U.K. who received up to three tim...